Home › Funds › GKV Capital Management Co., Inc. › VRTX

GKV Capital Management Co., Inc. position in VRTX

Vertex Pharma Inc · Health Care

GKV Capital Management Co., Inc. reported holding 5,980 shares of VRTX (Vertex Pharma Inc) in its Q3 2026 13F filing — a position valued at US$3.1M, representing 1.01% of its reported portfolio and ranking #31 among its reported holdings. GKV Capital Management Co., Inc. has disclosed VRTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)5.98K sh
Reported value held$3.13M
Portfolio Weight1.01%
First reportedQ4 2024
Last changeAdd
Updated2026-11-06

Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR

How GKV Capital Management Co., Inc.'s VRTX position evolved

GKV Capital Management Co., Inc. first disclosed a stake in VRTX in Q4 2024 at 3,738 shares (US$1.5M). The position peaked in Q3 2026 at 5,980 shares, worth US$3.1M. Across 8 filings, GKV Capital Management Co., Inc. increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,980 shares valued at US$3.1M — an increase of 219 shares quarter over quarter.. Notable position changes include a 30% increase in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 3.74K $1.51M New
Q1 2025 3.93K $1.90M Add
Q2 2025 4.03K $1.79M Add
Q3 2025 4.21K $1.65M Add
Q4 2025 4.30K $1.95M Add
Q1 2026 4.42K $1.97M Add
Q2 2026 5.76K $2.86M Add
Q3 2026 5.98K $3.13M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (Vertex Pharma Inc) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has GKV Capital Management Co., Inc. held VRTX?

GKV Capital Management Co., Inc. has disclosed VRTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is GKV Capital Management Co., Inc.'s current position in VRTX?

As of Q3 2026, GKV Capital Management Co., Inc. holds 5.98K shares of VRTX (Vertex Pharma Inc), valued at $3.13M, representing 1.01% of its reported portfolio and ranking #31.

Has GKV Capital Management Co., Inc. been buying or selling VRTX?

In the latest 13F filing (Q3 2026), GKV Capital Management Co., Inc. increased its position in VRTX. The position peaked in Q3 2026 at 5.98K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.